Clinical Trial Update: De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update describes de-adoption of beta-blocker therapy in patients with Stable Ischemic Heart Disease, indicating a shift away from routine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Stable Ischemic Heart Disease

Drugs mentioned

• beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: University of Alberta | Conditions: Stable Ischemic Heart Disease, Coronary Artery Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING